BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26617745)

  • 1. MicroRNA 181b promotes vascular smooth muscle cells proliferation through activation of PI3K and MAPK pathways.
    Li TJ; Chen YL; Gua CJ; Xue SJ; Ma SM; Li XD
    Int J Clin Exp Pathol; 2015; 8(9):10375-84. PubMed ID: 26617745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
    Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ_0002984 Promotes Cell Proliferation and Migration by Regulating miR-181b-5p/Vascular Endothelial Growth Factor Axis and PI3K-AKT Signaling Pathway in Oxidized Low-Density Lipoprotein-Treated Vascular Smooth Muscle Cells.
    Wang X; Ma C; Hou X; Zhang G; Huang Y
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):501-511. PubMed ID: 34954748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation.
    Lee J; Lim S; Song BW; Cha MJ; Ham O; Lee SY; Lee C; Park JH; Bae Y; Seo HH; Seung M; Choi E; Hwang KC
    J Cell Biochem; 2015 Apr; 116(4):598-608. PubMed ID: 25389122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
    Zhang Y; Chen X
    Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.
    Kim MH; Ham O; Lee SY; Choi E; Lee CY; Park JH; Lee J; Seo HH; Seung M; Choi E; Min PK; Hwang KC
    J Cell Biochem; 2014 Oct; 115(10):1752-61. PubMed ID: 24819721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
    Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
    J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
    Huang R; Huang Y; Zeng G; Li M; Jin Y
    Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
    Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway.
    Zhang W; Liu D; Han X; Ren J; Zhou P; Ding P
    Exp Cell Res; 2019 Jun; 379(2):214-224. PubMed ID: 30930138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway.
    Cai W; Zhang J; Yang J; Fan Z; Liu X; Gao W; Zeng P; Xiong M; Ma C; Yang J
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):621-632. PubMed ID: 31005375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MiR-21 on the proliferation and migration of vascular smooth muscle cells in rats with atherosclerosis via the Akt/ERK signaling pathway.
    Sun P; Tang LN; Li GZ; Xu ZL; Xu QH; Wang M; Li L
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2216-2222. PubMed ID: 30915769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
    Li X; Du JR; Yu Y; Bai B; Zheng XY
    J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.